Bovine respiratory disease (BRD) remains one of the most significant health and economic challenges in both beef and dairy production. While treatment costs are often the most visible impact, the real losses go much further. Reduced weight gain, delayed finishing, impaired feed efficiency and long-term performance losses can affect animals well beyond the initial disease episode.
In many cases, BRD is not just an acute problem – it is a hidden driver of reduced herd productivity. Understanding the role of key pathogens, such as Mannheimia haemolytica, is essential to improving prevention strategies.
A normal inhabitant – until conditions change
The bovine respiratory tract is not sterile. It contains a complex and dynamic microbial population, often referred to as the respiratory microbiome. Within this environment, bacteria such as M. haemolytica are commonly present without causing disease.
In healthy animals, less aggressive strains coexist with the host in a balanced state. This equilibrium plays an important role in maintaining respiratory health. However, this balance is highly sensitive to external and internal factors.
Stressors such as the ones below can disrupt this equilibrium and compromise the animal’s immune response:
- Transportation
- Weaning
- Weather fluctuations
- Commingling
- Viral infections
When this happens, M. haemolytica can shift from a harmless commensal organism to a primary pathogen.
From balance to disease: What triggers the shift
One of the key changes observed during disease development is the replacement of less virulent strains by more aggressive ones. Under normal conditions, strains such as serotype A2 are commonly found and are not associated with lung damage. Under stress and immune suppression, more virulent strains – particularly serotype A1 – rapidly dominate the respiratory tract.
This shift marks the transition from colonization to disease. Once established in the upper respiratory tract, these bacteria can be inhaled into the lungs, bypassing normal defence mechanisms and initiating infection. At this stage, the process can progress quickly, especially in animals already exposed to multiple stressors.
Why disease becomes severe
A key factor behind the severity of M. haemolytica infections is the production of leukotoxin. This toxin plays a central role in disease progression. At lower levels, leukotoxin can stimulate immune responses. However, at higher concentrations, it has the opposite effect:
- Destruction of immune cells
- Amplification of inflammation
- Increased lung tissue damage
As the inflammatory response escalates, lung tissue becomes consolidated and gas exchange is impaired. Lesions often develop rapidly and can spread within the lung, leading to fibrinous pneumonia or pleuropneumonia.
Importantly, much of the damage observed is not caused solely by the bacteria but by the interaction between the pathogen and the animal’s own immune response. This helps explain why some outbreaks result in severe clinical signs even when bacterial presence alone might not seem overwhelming.
Beyond bacteria: A multifactorial problem
BRD should not be viewed as a single-agent disease. It is a multifactorial condition involving the interaction between:
- Pathogens (viral and bacterial)
- Environmental stressors
- Host immunity
Viruses such as bovine respiratory syncytial virus, infectious bovine rhinotracheitis or bovine viral diarrhea often play a critical role by weakening immune defenses, allowing bacteria like M. haemolytica to proliferate more aggressively.
Management practices also influence disease dynamics. High stocking density, poor ventilation, nutritional stress and mixing animals from different sources all increase the likelihood of disease. For producers, this means that controlling BRD requires a broader approach than simply reacting to clinical cases.
Rethinking prevention: Moving beyond treatment
Historically, BRD control has relied heavily on antibiotic use, particularly during high-risk periods. While antibiotics remain an important tool, this approach has limitations:
- Growing concern around antimicrobial resistance
- Limited impact on underlying risk factors
- Reduced effectiveness in preventing severe lung damage
Today, there is increasing recognition that prevention must focus on reducing disease severity and improving resilience, rather than relying solely on treatment. This has led to a greater emphasis on:
- Stress reduction
- Optimized management practices
- Strengthening immune protection
Targeting what matters: The role of leukotoxin
Recent advances in BRD prevention have focused on targeting key virulence factors such as leukotoxin. Because leukotoxin is directly involved in immune cell destruction and lung damage, strategies that reduce its impact can significantly improve disease outcomes. Rather than focusing only on the presence of bacteria, this approach aims to:
- Reduce severity of clinical signs
- Limit lung damage
- Improve recovery and performance
This represents an important shift in how respiratory disease is approached in modern cattle production systems.
Practical considerations for the field
Producers and veterinarians can take several practical steps to reduce the impact of M. haemolytica:
- Manage stress proactively – Minimize stress during key periods such as weaning, transport and commingling.
- Optimize environment – Ensure adequate ventilation, reduce overcrowding and maintain good hygiene.
- Support immunity early – Focus on colostrum management and early-life health to build stronger immune responses.
- Implement structured prevention programs – Work with a veterinarian to develop vaccination and herd health strategies adapted to the operation.
- Monitor herd performance – Subclinical respiratory disease often goes unnoticed but impacts productivity.
The bottom line
M. haemolytica is not simply an external threat – it is a normal inhabitant of the respiratory tract. The challenge is not eliminating the bacteria but preventing the conditions that allow it to become a pathogen. When stress, immune suppression and environmental factors align, the balance is lost – and respiratory disease follows. By focusing on prevention, reducing stress and targeting key disease mechanisms, producers can move from reactive treatment to proactive herd health management.
This article has been adapted for a producer audience by Rogério Eduardo de Souza Júnior, technical sales specialist for HIPRA Canada, from technical work by Dr. Wojciech Ptak, DVM.
This is the third article in the Detect and Protect technical series from HIPRA Canada, dedicated to advancing cattle health. We explore the causes, diagnosis and prevention of bovine respiratory disease (BRD) to empower producers with science-based insights and solutions.
